Publications by authors named "Deborah Wexler"

Claim this Profile
C
Comparative healthcare resource utilization and costs of empagliflozin and GLP-1 receptor agonists in type 2 diabetes.
Phyo Than Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J Wexler, Robert J Glynn

Diabetes Obes Metab· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning for predicting cardiovascular events in older adults with type 2 diabetes using Medicare claims and electronic health records.
Phyo T Htoo, Julie M Paik, Brendan M Everett, Robert J Glynn, Katsiaryna Bykov, Deborah J Wexler

J Clin Epidemiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes.
Yichen E Fang, Julie M Paik, Janinne Ortega-Montiel, Helen Tesfaye, Deborah J Wexler

Diabetes Care· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes.
Salvatore Crisafulli, Wajd Alkabbani, Julie M Paik, Katsiaryna Bykov, Ali Tavakkoli, Deborah J Wexler

Ann Intern Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes Collaborative Care for Young Adults: A Formative, Mixed Methods Study of a Pragmatic, Multidisciplinary Care Model for Young Adults With Diabetes in an Adult Center.
Janaki D Vakharia, Maria Theodorakakis, Carolin Schulte, Daniel Shinnick, Tanayott Thaweethai, Deborah Wexler

Endocr Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medications Associated with Increased Risk of Hypoglycemia in Older Adults on Sulfonylureas: A High-Throughput Case-Crossover-Based Screening Study.
Sungho Bea, Elisabetta Patorno, Georg Hahn, Julie M Paik, Deborah J Wexler

Drug Saf· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sociodemographic and behavioral factors associated with diet quality in low-income adults with prediabetes and type 2 diabetes.
Kristine D Gu, Daniel Shinnick, Tanayott Thaweethai, Jessica Cheng, Deborah J Wexler

Prim Care Diabetes· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1RA and the risk of non-arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes: A population-based study.
Helen Tesfaye, Julie M Paik, Deborah J Wexler, Jimena Tatiana Hathaway, Elaine W Yu

Diabetes Obes Metab· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and Treatment of Type 2 Diabetes in Adults: A Review.
Rita R Kalyani, Joshua J Neumiller, Nisa M Maruthur, Deborah J Wexler

JAMA· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Uptake and Racial, Ethnic, and Socioeconomic Disparities in the Use of Continuous Glucose Monitoring Devices Among Insulin-Treated Older Adults With Type 2 Diabetes.
Wajd Alkabbani, Sara J Cromer, Dae Hyun Kim, Julie M Paik, Katsiaryna Bykov, Deborah J Wexler

Diabetes Care· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Hospitalizations With Randomized Glycemia-Lowering Treatment in GRADE.
Daniel S Hsia, Naji Younes, Alokananda Ghosh, Erin J Kazemi, Heidi Krause-Steinrauf, Deborah J Wexler

Diabetes Care· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empagliflozin versus DPP4i or GLP-1RA for the risk of nephrolithiasis in patients with type 2 diabetes: Research letter from the EMPRISE cohort study.
Helen Tesfaye, Julie M Paik, Heidi Zakoul, Niklas Schmedt, Deborah J Wexler

Diabetes Obes Metab· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight Gain Was Associated With Worsening Glycemia and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes Independent of Diabetes Medication in the GRADE Randomized Controlled Trial.
Deborah J Wexler, W Timothy Garvey, Alokananda Ghosh, Erin J Kazemi, Heidi Krause-Steinrauf

Diabetes Care· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization Trends of Dual GIP/GLP-1 Receptor Agonist, Newer Glucose-Lowering Medications, and Anti-Obesity Medications Among Patients With Chronic Kidney Disease With and Without Type 2 Diabetes.
Panupong Hansrivijit, Janinne Ortega-Montiel, Deborah J Wexler, Elisabetta Patorno, Julie M Paik

Kidney Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Utilization of Glucose- and Weight-Lowering Medications After Tirzepatide Approval in the United States : A Population-Based Cohort Study.
John W Ostrominski, Janinne Ortega-Montiel, Helen Tesfaye, Caroline Alix, Elyse DiCesare, Deborah J Wexler

Ann Intern Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adapting a Text Messaging Intervention to Improve Diabetes Medication Adherence in a Spanish-Speaking Population: Qualitative Study.
Jacqueline Seiglie, Seth Tobolsky, Ricaurte Crespo Trevino, Lluvia Cordova, Sara Cromer, Deborah Wexler

JMIR Hum Factors· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 diabetes disease and management patterns across a large, diverse healthcare system: Issues and opportunities for guideline-directed therapies.
Alexander J Blood, Lee-Shing Chang, Caitlin Colling, Gretchen Stern, Daniel Gabovitch, Deborah J Wexler

Am Heart J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary Disease Exacerbations in Patients With Type 2 Diabetes.
Avik Ray, Julie M Paik, Deborah J Wexler, Sushama K Sreedhara, Katsiaryna Bykov

JAMA Intern Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Individual Sodium-Glucose Cotransporter 2 Inhibitors.
HoJin Shin, Julie M Paik, Brendan M Everett, Elyse DiCesare, Caroline Alix, Deborah J Wexler

JAMA Intern Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empagliflozin and the Risk of Retinopathy in Patients With Type 2 Diabetes.
Helen Tesfaye, Julie M Paik, Miin Roh, Phyo T Htoo, Heidi Zakoul, Deborah J Wexler

JAMA Ophthalmol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization Trends of Glucose-Lowering Medications Among Adult Kidney Transplant Recipients with Type 2 Diabetes in the United States.
Panupong Hansrivijit, Helen Tesfaye, Deborah J Wexler, Reza Abdi, Elisabetta Patorno

J Clin Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enrollment strategies in the era of digital revolution: Experience from a remote health management program.
Shahzad Hassan, Lee-Shing Chang, Daniel Gabovitch, Jacqueline Chasse, Gretchen Stern, Deborah Wexler

Am Heart J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study.
Wajd Alkabbani, Karine Suissa, Kristine D Gu, Sara J Cromer, Julie M Paik, Deborah J Wexler

BMJ· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for recurrent nephrolithiasis among patients with pre-existing nephrolithiasis or gout: target trial emulation studies.
Natalie McCormick, Chio Yokose, Na Lu, Deborah J Wexler, J Antonio Aviña-Zubieta

BMJ· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finding Truth in Observational and Interventional Studies in Diabetes and Cardiovascular Disease.
Brendan M Everett, Deborah J Wexler

J Am Coll Cardiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis